• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

How high is a high risk? Prioritising high-risk individuals in an influenza pandemic

tetano

Editor, Senior Moderator
Vaccine. 2014 Oct 22;32(52):7167-7170. doi: 10.1016/j.vaccine.2014.10.020. [Epub ahead of print]
How high is a high risk? Prioritising high-risk individuals in an influenza pandemic.
Littmann J.
Author information
Abstract

Pandemic contingency plans frequently define priority groups that are given preferential access to influenza vaccine. One of the most commonly named groups for prioritisation is that of high-risk individuals. However, current models of categorisation are unsatisfactory in a number of ways. It will be argued that existing vaccination strategies fail to adequately define what kind of risks are being considered and how, as well as on the basis of which information, these risks are calculated. Moreover, it will be suggested that existing vaccination strategies fail to specify of what magnitude a risk has to be, in order to be categorised as 'high'. Finally, it shall be argued that a mere focus on the size of a risk factor may lead policy makers to overlook underlying concerns of distributive justice.

Copyright ? 2014 Elsevier Ltd. All rights reserved.
KEYWORDS:

High-risk individuals; Influenza pandemic; Prioritisation; Vaccination ethics

PMID:
25454881
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25454881
 
Back
Top Bottom